The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines
EPHA #A2MDialogues

25 November 2020

16:00-17:00 CET


Our fourth dialogue in a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe. 

Following the publication of the EU’s Pharmaceutical Strategy by the European Commission, senior representatives of the upcoming EU Presidencies (Portugal & Slovenia) and the Netherlands offer their perspective on what should be prioritised and debate next steps in European pharmaceutical policy.  


Rui Ivo Santos  


INFARMED, Portugal


Momir Radulovic

Executive Director

Slovenian Medicines Agency

Marcel van Raaij


Medicines & Medical Technologies

Dutch Ministry of Health

Moderated by

Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines

European Public Health Alliance

On social media

Find out more about EPHA’s other A2M Dialogues below

Getting it right: Recommendations for a European BARDA

Pharma & COVID19: Winners, losers, prospects

The EU's IP strategy: Enabler or barrier?

Unleashing meaningful innovation through regulatory reform




Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines, EPHA

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!